Immunologic Paralysis: Clinical Trials

2 trials for Immunologic Paralysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Immunologic Paralysis: new trials by email Literature Review of Immunologic Paralysis trials Research Report on Immunologic Paralysis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes
esmolol - Sepsis, Lymphocyte Disorder T
Phase 2CompletedLin Chen1502021-01-012024-05-29
Immune Homeostasis in Sepsis and Septic Shock
transcriptomics, flow-cytometry, cytokines - Sepsis, Immunologic Paralysis
RecruitingCharles University, Czech Republic2002020-09-012024-08-21

Narrower conditions

Sepsis (2)  ·  Autonomic Nervous System Diseases (1)  ·  Cytokine Release Syndrome (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Shock, Septic (1)

Broader conditions

Infections (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Shock (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Immune System Diseases (1)  ·  Nervous System Diseases (1)

Interventions

Cytokines (1)  ·  Flow Cytometry (1)  ·  Gene Expression Profiling (1)  ·  esmolol (1)

Sponsors

Charles University, Czech Republic (1)  ·  Lin Chen (1)

Countries

China (1)  ·  Czechia (1)

Top investigators

Lin Chen, doctoral (1)  ·  Thomas Karvunidis, MD, PhD (1)

Results publications

PMID 38240494, PMID 40421209